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1. Foreword  
1.1 Amniotic membrane 
The fetal membrane is composed by the chorion, allantois and amnion. The AM 
is the inner layer. It consists of a single layer of ectodermally derived cuboidal to 
columnar cells, which form the epithelium, a basement membrane that connects 
with the chorion by a layer of mesenchyme which contains large amounts of 
collagen (stroma). Amniotic basement membrane and stroma contain cytokines, 
proteoglycans, collagen type I, III, IV, V and VII, laminin and fibronectin.7-12  
Different interesting properties of the AM have been described. Amniotic 
basement membrane, by serving as a “transplanted basement membrane”, acts as 
a new healthy substrate that facilitates migration of epithelial cells, reinforces 
adhesion of basal epithelial cells, promotes epithelial differentiation, and 
prevents epithelial apoptosis.8,10 Additionally AM produces various growth 
factors such as basic fibroblast growth factor, hepatocyte growth factor and 
transforming growth factor β, that can stimulate epithelialisation and reduce scar 
formation.8,10,12 AM also inhibits protease activity,8,12 has anti-inflammatory,8,10,12-
14 anti-angiogenic8,10,13 and antifibrotic effects.8,10,12,15  
Several factors are involved in the anti-inflammatory action: down-regulation 
through TGFβ-signaling system; preclusion of polymorphonuclear cell 
infiltration; suppression of pro-inflammatory cytokines, including IL-1α, IL-2, 
IL-8, interferon λ, tumor necrosis factor-β, TNF-α, basic fibroblast growth 
factor and platelet derived growth factor.8,10-14 AM also attracts and sequesters 
inflammatory cells infiltrating the ocular surface.8 
Anti-angiogenic effects may be explained by the anti-inflammatory action and by 
the release of soluble anti-angiogenic factors from the epithelial and 
mesenchymal cells of amniotic membrane, such as interleukin-1 receptor 
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antagonist, tissue inhibitors of metalloproteinase (TIMP), collagen 18, IL-10, 
thrombospondin-1 and pigment epithelium-derived factor (PEDF).8,10,13  
AM stromal matrix suppresses TGFβ, proliferation and myofibroblastic 
differentiation of normal corneal, limbal and conjunctival fibroblast.8,12,15 This 
action explains why AM helps reduce scars formation after conjunctival and 
corneal surface reconstruction.14   
Finally it has been noted that AM has antibacterial and antiviral activities. This is 
explained by the presence of various compounds that promote anti-microbial 
immunity, such as interleukins, interferons, TNF-α, activin A, inhibin A, pre-B-
cell colony-enhancing factor and leukemia inhibitory factor.8,10,14  
The non-immunogenicity of the AM was believed to be another important 
property. It was thought that AM did not express HLA-A, -B, or –DR antigen 
since after transplantation it did not undergo rejection. Subsequent studies have 
shown class 1 antigen and co-manifestation of class 1a (HLA-A, -B,-C, -DR) and 
class 1b (HLA-G and HLA-E) antigen in amniotic epithelium and stroma. The 
techniques of AM processing and preservation render all the amniotic cells 
nonviable and hence its immunogenicity is of no consequence.10,16 
AM may be used either as a graft (inlay) or a patch (overlay) or in multiple layers. 
In the inlay technique the AM is tailored to the size of the defect and is meant to 
act as a scaffold for the epithelial cells. The AM is secured with its basement 
membrane or epithelial side up to allow migration of the surrounding epithelial 
cells on the membrane.10,11 In the overlay technique the AM is used akin to a 
biological contact lens in order to protect the healing surface defect beneath and 
to act as barrier to protect the cornea from inflammatory cells and proteins in 
the tear film. The AM is secured with its epithelial side up and it either falls off 
or is removed.10,11 In the filling-in technique the entire depth of an ulcer crater is 
filled with small pieces of AM trimmed to the size of the defect. The orientation 
of these pieces does not matter. The most superficial piece is placed with the 
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basement membrane side up and sutured as an inlay graft enabling corneal 
epithelium to grow over it.10,11  
In this study we are illustrating the use of amniotic membrane transplantation 
for ocular surface reconstruction in different diseases in cats, dogs and horses. In 
the following paragraphs we will briefly describe the ocular conditions that we 
treated with this procedure.  
1.2 Feline corneal diseases 
1.2.1 Feline corneal sequestrum 
Corneal sequestrum (corneal nigrum, corneal mummification, corneal necrosis 
or necrotizing keratitis) is a disease unique to the feline species, characterized by 
a localized necrosis of corneal epithelium and superficial stroma that can 
progress to the deeper stromal layers.1-3 The lesion is brown and can show 
different degrees of vascularization. Brachycephalic cats seem to be predisposed 
to corneal sequestrum, suggesting that it can occur following chronic exposure 
of the central corneal.1,2,4 Other predisposing causes of the lesion are feline 
herpes virus (FHV-1)5 and chronic corneal irritation, such as keratitis secondary 
to palpebral defects (eg. entropion).2,6 The most effective therapy is still 
controversial, but most veterinary ophthalmologists treat the lesion with a 
lamellar keratectomy with or without secondary placement of a pedicle 
conjunctival graft. The graft seems to reduce the recurrence rate of the 
sequestrum after keratectomy and can provide a tectonic support in case of deep 
keratectomy, although it is associated to secondary corneal scars of varying 
density.1 Lamellar keratoplasty,4 corneoconjunctival transposition2 and 
penetrating keratoplasty3 have been described as surgical treatment of feline 
corneal sequestrum, with a possible improved cosmetic outcome than 
conjunctival graft. 
1.3 Canine corneal diseases 
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1.3.1 Dermoid 
Dermoids are choristoma, or congenital circumscribed overgrowth of 
microscopically normal tissue in an abnormal place. They are described in 
different species. The tissue may involve conjunctiva, third eyelid, eyelid margin, 
limbus or cornea in various combination. In dermoids containing hair follicles, 
hair grows from the surface, causing conjunctival and corneal irritation, evident 
as corneal opacity, conjunctival hyperemia and ocular discharge. The mass, 
depending on its location, can be a source of severe ocular pain. If on the lid 
margins, it prevents the normal blinking reflex and therefore proper eye 
lubrication. Dermoids located on the cornea are a physical barrier preventing 
normal vision. Tratement requires careful surgical excision with 
conjunctivectomy, combined with keratectomy if they cross the limbus.34 
1.3.2 Stromal corneal ulcer 
A corneal ulcer is any keratopathy in wich there is a loss of epithelium. When 
this first layer is damaged the surface of the eye is no longer smooth and bacteria 
can now enter the eye causing the eye to become painful. The corneal ulcer can 
deepen and widen and involve deeper layers of the cornea.   
The cause of a corneal ulcer can be anything that causes an abrasion to the eye. 
Dogs that rub their face with their paw, scratch to the eye by another animal, 
thorns, grass seeds, eyelid/cilia abnormalities, tear deficiencies, and foreign 
objects are all common causes for ulcers. 
An ulcer should heal within 7 days and without progression to involve the 
stroma (“simple ulcer”). Complicated corneal ulcers involved the stroma and/or 
persist longer than 7 days. Topically medication with antibiotics  is indicated for 
all corneal ulcers.  
Ulcers that are rapidly progressive or that have areas of stromal melting, stromal 
loss, or marked cellular infiltrate are considered complicated and assumed to be 
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infected. In these cases medical therapy could not be enough, and surgical 
treatment is suggested. Conjunctival grafts can provide mechanical support for a 
thin or weakened cornea, supply of serum, which contains anticollagenases and 
growth factors, source of actively replicating fibroblasts for collagen regeneration 
in the stroma, delivery of systemic antibiotics. The disadvantage of the 
conjunctival graft is the evident corneal scar that could induce partial vision 
impairement.34 Porcine small intestinal submucosa (SIS) grafts, amniotic 
membrane grafts, corneaoscleral/coreoconjunctival transposition, lamellar 
corneal grafts are other surgical options described. 7,34  
1.4 Equine corneal disease 
1.4.1 Melting ulcer 
Equine corneal ulceration is one of the most important disease of the horse 
cornea is a potentially sight-threatening disease requiring early clinical diagnosis, 
laboratory confirmation, and appropriate medical and surgical therapy.33  
Infection by bacteria and fungi should be considered in every corneal ulcer. 
Bacteria living on the surface of the cornea are able to attach to the corneal cells 
once the epithelium has been damaged. Many bacterial species cause corneal 
ulcers in horses, but Gram-negative bacteria such as Pseudomonas and Gram-
positive bacteria such as Staphylococcus and Streptococcus are particularly feared. 
Infection of corneal ulcers in horses is common. Bacteria recruit white blood 
cells that produce enzymes to the ulcer site; these enzymes digest collagen in the 
stroma and greatly speed the progression of an ulcer. Enzymatic activity in 
corneal ulcers is referred to as "melting" and gives a grayish, liquefied appearance 
around the ulcer. Melting is a serious problem for the horse cornea.31,33  
Corneal ulcers are painful and stimulation of corneal sensory nerves causes 
painful inflammation of the iris (anterior uveitis). Other common clinical signs 
of corneal ulcers include tearing and corneal cloudiness.  
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Corneal ulcers in horses must be aggressively treated in order to preserve vision.  
Subpalpebral tubing treatment systems might be necessary for medicating horses 
with painful eyes. The primary treatment for bacterial corneal ulcers is intensive 
administration of antibiotics. Broad-spectrum antibiotics are usually administered 
three to eight times per day to kill bacteria in the eyes of horses with ulcers. 
Prevention of collagen breakdown and ulcer progression is also important in 
ulcer therapy. Enzymes derived from white blood cells in the tears can be 
powerful forces in the destruction of the corneal stroma, and can cause rapid 
deepening of ulcers. Topical corticosteroids increase this damaging enzyme 
activity and should not be used in the treatment of corneal ulcers.33  
Serum from the blood of the horse contains proteins with anti-melting activity  
and can be placed in the eye hourly for melting ulcers in horses. 
Ethylenediaminetetraacetic acic (EDTA 0.2%) and Acetylcysteine (5-10%) can 
also be used topically for its melting enzyme-inhibiting properties. Treatment of 
the anterior uveitis found with corneal ulcers in horses is critical. Topical 1% 
atropine is usually given to relieve pain and dilate the pupil. Non steroidal anti-
inflammatory drugs are used orally, intramuscularly, or intravenously to relieve 
eye pain and inflammation. To increase lost corneal thickness and strength, deep 
corneal ulcers threatening rupture of the eye and corneas that have ruptured  
require conjunctival flap placement or corneal transplantation surgery.33 Porcine 
small intestinal submucosa (SIS) grafts, amniotic membrane grafts, 
corneaoscleral/coreoconjunctival transposition, lamellar corneal grafts are other 
surgical options described. 8,31,33 
1.4.2 Fungal ulcer 
Keratomycosis refers to "kerato," meaning corneal disease, and "mycosis" 
referring to fungal infection. The term keratomycosis refers to any corneal 
disease caused by fungus; these diseases include ulcers, abscesses, and iris 
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prolapses. Several species of septate filamentous fungi are common to the equine 
eye (Fusarium, Aspergillus, and Penicillium).33  
Fungal keratitis are more common and the clinical signs are the most severe in 
horses living in warm, humid geographic regions Seasonality of infection in Italy 
shows that fungal ulcers occur with the majority of cases in May through 
November.  
The pathogenesis of fungal ulcers (ulcerative keratomycosis) commonly begins 
with different severity of corneal trauma resulting in exposure of the stroma, and 
stromal invasion by the fungal organisms living on the surface of the horse eye 
or in the environnement. Further corneal destruction results from the release of 
enzymes from the fungi, white blood cells, and corneal cells.33  
Ulcers infected with fungi range from minor corneal epithelial abrasions to 
superficial plaques, to extremely deep, severe ulcers. Diagnosis of keratomycosis 
is based on finding fungal hyphae or yeast on cytologic (cellular) examination of 
a corneal scraping, culture of the corneal lesion, or surgical biopsy. Fungal 
hyphae are frequently found deep in the equine cornea rather than on the 
surface.33 
Treatment must be directed against the fungi as well as against the corneal and 
intraocular inflammatory responses that occur following fungal replication and 
death of the hyphae. Anti-fungal drug treatment is often required for an 
extended period to achieve complete fungal destruction and resolution of the 
clinical . Antibiotic treatment is also indicated with keratomycosis as concurrent 
bacterial infection is relatively common. Topical corticosteroids are 
contraindicated in keratomycosis in horses as they can worsen the disease by 
enhancing fungal replication, predisposing the cornea to further fungal infection, 
and decreasing the effectiveness of anti-fungal drugs.33 Combined medical and 
surgical therapy is indicated if ulcers are extremely deep, if they are not 
responding to medical treatment, or if they worsen in spite of medical treatment. 
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Surgeries for keratomycosis include conjunctival grafts, amniotic membrane 
transplantation and full-thickness corneal transplantation.8,33  
1.4.3 Immune-mediate keratitis 
Immune-mediate  keratitis (IMMK) is characterized by chronic nonulcerative 
keratitis with cellular infiltrate and corneal vascularization. Other characteristic 
features of this disease are lack of secondary uveitis or severe discomfort, no 
micro-organisms and therapeutic response to anti-inflammatory medications.33,35 
The possible pathogenesis of IMMK in horses is that the immune system has 
recognized a self-antigen in the cornea (i.e. molecular mimicry) or a foreign 
protein or organism antigen within the cornea. An underlying infectious agent 
may be either the inciting or perpetuating cause (or both) in many horses with 
IMMK. This organism may be directly inciting active inflammation or may have 
induced immunologic cross-reaction with self-antigen in the cornea.35 Both 
medical and surgical therapies could be indicated. Topical steroids or 
cyclosporine could be effective.33 Removal of this inciting antigen via 
keratectomy may eliminate the source of the immune reaction and stop the 
inflammatory process.35  
1.4.4 Corneal edema 
 Normal corneal hydration reprents the balance between the fluid leak across the 
corneal endothelium and the extrusion of fluid via the endothelial metabolic 
pump.  Corneal edema is characterized  by a bluish opacity that could cause 
visual impairment and potentially recurrent corneal ulcers resulting from rupture 
of epithelial bullae.  The possible causes of corneal edema could be: primary 
endothelial degeneration,  glaucoma or  uveitis. Topical hyperosmotic agents are 
descrive for therapy, but they don’t induce a resolution of the clinical signs.33  
1.4.5 Corneal Squamous Cell Carcinoma                                                 
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Squamous cell carcinoma (SCC) is the most common tumor affecting the eye in 
horses. The way the tumor grows and spreads might be related to exposure to 
the ultraviolet (UV) component of solar radiation, periocular pigmentation, and 
an increased genetic susceptibility to tumor formation. The UV component is 
the most plausible carcinogenic agent associated with SCC, as it targets the 
tumor suppressor gene p53 that is altered in equine SCC.30,33  
Horse breeds with the least ocular and periocular pigmentation appear to be at 
increased risk for ocular SCC. Draft horses have a higher prevalence, followed 
by Appaloosas and Paints, with the least prevalence found in Arabians, 
Thoroughbreds, and Quarter Horses.30,33 The prevalence of SCC increases with 
age. 
The cornea, conjunctiva, and limbus are the most commonly affected area. The 
appearance of corneal SCC varies, depending on the duration of the lesion.7,30,33 
These tumors are generally pink, fleshy masses that are raised or flat. Diagnosis 
is by biopsy, and treatment selection depends on tumor location, tumor size and 
extent of tumor invasion. Surgical excision alone could not be enough and 
should be followed by either radiation, cryotherapy, hyperthermia, or 
intralesional chemotherapy to prevent recurrence.7,8,30,33  
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2. Objectives 
The use of  amniotic membrane (AM)  for corneal surface reconstruction is 
usually associated to a high degree of corneal clarity both in human and animal.7,8 
The purpose of this study is to evaluate clarity of the cornea (esthetic outcome) 
and the quality of the vision (functional outcome) after equine amniotic 
membrane transplantation for ocular surface reconstruction in cats, dogs and 
horses affected by different ocular diseases.  In cats the work is a pilot study for 
the use of this surgical technique after lamellar keratectomy for corneal 
sequestra.  
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3. Materials and methods 
3.1 Amniotic membrane preparation 
The AM was obtained from the placenta of a mare undergoing cesarean section. 
The AM was dissected from the chorion, cleaned with saline solution first, then 
with povidone iodine solution 0.1% and finally with a gentamicin solution 0.2%. 
All 3 solutions were alternated 3 times. The membranes were placed on a 
nitrocellulose paper with the epithelial surface up, cut into 5 x 5 cm pieces and 
stored in 98% glycerin  at room temperature. A sample of the membrane was 
placed in formalin and submitted for histopathologic examination while a second 
sample was submitted for bacterial culture to confirm asepsis. The median time 
of storage of the AM before use was 66.15 days (range 1-184 days). 
The histopathologic appearance of the  AM at different times of preservation 
(fresh, after 8 weeks and after 16 weeks) was also compared. 
3.2 Feline cases 
AM transplantation was performed in six cats (seven eyes) diagnosed with 
corneal sequestra. Data collected for each case included breed, gender, age, eye 
affected, clinical signs and information about the sequestrum (size, depth, 
location and vascularization). Presence of ophthalmic lesions potentially related 
to corneal sequestrum formation such as corneal erosion or entropion were also 
recorded. Complete blood count (CBC), serum chemistry, urinalysis, feline 
leukemia virus (FeLV) and feline immunodeficiency virus (FIV) tests (ELISA) 
were performed in all cases.  
The affected eye was routinely prepared for ocular surgery with 0.1% povidone 
iodine solution. A lamellar keratectomy was performed in all cats. A curvilinear 
incision was made using a #64 Beaver blade, following along and outside the 
margin of the corneal lesion. A Martinez corneal dissector (Storz, St Louis, MO, 
USA) was used to separate the corneal lamellae and create a corneal flap, 
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containing the entire lesion. Westcott tenotomy scissors were then used to 
sharply dissect the flap from the remainder of the cornea. The corneal defect 
was covered by an equine AM graft,  that was cut to size, placed over the entire 
keratectomy bed and then sutured with AM stroma against the exposed corneal 
stroma to the margin of the keratectomy with 8-0 Vicryl (Vicryl®, Ethicon) in an 
interrupted or continuous pattern. The keratectomy sample and a small piece of 
the AM used for each eye were placed in formalin and submitted for 
histopathologic examination. Tobramycin (Tobral®, Alcon Italia) q 8 hrs was 
given topically after surgery until healing occurred and oral doxycycline 
(Ronaxan®,Merial Italia) 10mg/Kg q 24 hrs was administered for 10 days.  
3.3 Canine cases 
AM transplantation was performed in three dogs (three eyes) diagnosed with 
stromal corneal ulcer or dermoid. Data collected for each case included breed, 
gender, age, eye affected, clinical signs and information about the lesion (size, 
depth, location and vascularization). Complete blood count (CBC), serum 
chemistry and urinalysis were performed in all cases.  
The affected eye was routinely prepared for ocular surgery with 0.1% povidone 
iodine solution. The excision of the dermoids was performed in a similar manner 
as described for feline cases but extending on the conjunctiva and on the lateral 
cantus when affected. In the corneal stromal ulcer the necrotic and infiltrated 
tissue around the lesion was removed by #64 Beaver blade and Westcott 
tenotomy scissors. In all cases the corneal/conjunctival defect was covered by an 
equine AM graft,  that was cut to size, placed over the entire keratectomy bed 
and then sutured, with AM stroma side down, to the margin of the 
keratectomy/conjunctivectomy with 8-0 Vicryl (Vicryl®, Ethicon) in an 
interrupted or continuous pattern. The cantus was sutured with a 6-0 Vicryl 
(Vicryl®, Ethicon) in a simple interrupted manner with a “eighth shape” knot on 
the margin. The removed lesions and a small piece of the AM used for each eye 
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were placed in formalin and submitted for histopathologic examination. 
Tobramycin (Tobral®, Alcon Italia) q 8 hrs was given topically after surgery until 
healing occurred and oral doxycycline (Ronaxan®,Merial Italia) 10mg/Kg q 24 
hrs was administered for 10 days.  
3.4 Equine cases 
AM transplantation was performed in eleven horses (eleven eyes) diagnosed with 
corneal melting ulcer, corneal fungal ulcer, corneal edema, immune-mediated 
keratitis or corneal squamous cell carcinoma.. Data collected for each case 
included breed, gender, age, eye affected, clinical signs and information about the 
lesion (size, depth, location and vascularization). Complete blood count (CBC), 
serum chemistry and urinalysis were performed in all cases.  
The affected eye was routinely prepared for ocular surgery with 0.1% povidone 
iodine solution. A lamellar keratectomy was performed in all cats extending to 
the limbus and conjunctiva in the SCC cases. A curvilinear incision was made 
using a #64 Beaver blade, following along and outside the margin of the corneal 
lesion. A Martinez corneal dissector (Storz, St Louis, MO, USA) was used to 
separate the corneal lamellae and create a corneal flap, containing the entire 
lesion. Westcott tenotomy scissors were then used to sharply dissect the flap 
from the remainder of the cornea. The corneal defect was covered by an equine 
AM graft,  that was cut to size, placed over the entire keratectomy bed and then 
sutured with AM stroma against the exposed corneal stroma to the margin of the 
keratectomy with 8-0 Vicryl (Vicryl®, Ethicon) in an interrupted or continuous 
pattern. The keratectomy sample and a small piece of the AM used for each eye 
were placed in formalin and submitted for histopathologic examination. Flunixin 
meglumine (1mg/Kg/24 hrs for 3 days, then 0,5 mg/Kg/24 hrs for 5-7 days) 
was administered intramuscularly. Tobramycin q 8 hrs, atropine 1% q 12 hrs and 
itraconazole 1%  q 6-8 hrs (for fungal ulcers only) were given topically after 
surgery until healing occurred. 
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4. Results 
4.1 Amniotic membrane 
Histopathologic examination of the AM showed that the epithelium survives for 
up to 60 days after preservation. Fresh AM (1 week of preservation in glycerol) 
was composed of a single layer of cuboidal epithelial cells resting on a thin 
basement lamina that was, in turn, connected to the amniotic mesoderm. The 
latter had an acellular compact layer, closest to the epithelium, and a deeper layer 
in which a network of loosely dispersed fibroblast-like cells was recognizable 
(Fig 1a). After 60 days of preservation in glycerol the epithelial cell lining was still 
recognizable although it appeared discontinuous with shrinkage of single 
epithelial cells, while mesoderm was generally more dense (Fig. 1b). After 4 
months (120 days) of preservation the amniotic epithelium was no longer 
recognizable and the stroma appeared more compacted and dehydrated (Fig. 1c 
). 
No correlation was found between the state of preservation of AM and the 
outcome of surgical procedure.  
 
 
 
 
 
30 
 
 
                                     
 
Figure 1. Histological sections (6 mm) of amniotic membrane at different times of preservations (a) 
fresh amniotic membrane, with an intact epithelium layer. (b) amniotic membrane after 8 weeks of 
preservation in glycerol. The epithelial layer is discontinuous and the stroma is compact discontinuous. 
(c) amniotic membrane after 16 weeks of preservation. The epithelium is totally disappeared  the 
stroma is dehydrated and compact. H&E, original magnification 400x. (Courtesy Dr. Chiara Giudice) 
 
 
4.2 Cats  
The sequestrum affected the right cornea in one cat, the left cornea in four cats 
and both corneas in one cat. Breeds affected included four Persian and two 
domestic shorthair cats. There were four spayed females, one intact male and 
one castrated male. The median age at the time of treatment was 5.3 years (range 
2-12 years). Additional findings included medial entropion of the lower eyelid in 
four cats and persistent epithelial erosion around the sequestrum in one eye. The 
depth of one sequestrum was less than 1/3 of the corneal thickness, three were 
a b 
c 
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between 1/3 and 2/3 and three were more than 2/3 corneal thickness depth. 
Corneal vascularization was absent in two eyes, moderate in two eyes and severe 
in three eyes (Fig. 2a). One cat was FeLV positive and one was leukopenic 
because of myelosuppression of unknown origin (Table 1). 
After surgery no blepharospasm was noted. In all the eyes there was an epithelial 
proliferation over the AM within the first 2-4 days after surgery (Fig 2b). In five 
eyes there was a second phase of corneal granulation tissue proliferation over the 
next 2-5 weeks (Fig. 2c) and a third phase of corneal clearing in the following 
weeks. During this last phase an almost complete regression of the preexisting 
vascularization and granulation tissue was noted with  excellent corneal 
transparency (Fig. 2d). One eye showed the formation of a brown area in the 
center of the AM (Fig. 3 a-b-c) in the first weeks after transplantation. The 
corneal sequestrum of this eye was less than 2/3 of the corneal thickness deep 
and it was completely excised. The lesion involved approximately 80% of 
corneal surface and the proliferation of the granulation tissue took some time to 
invade all the AM. The brown area was suspected to be  partial necrosis of the 
last vascularized point that gradually disappeared with the regression of the 
granulation tissue (Fig. 3d).  
Two eyes had complications. In one cornea (case 2, table 1) partial necrosis and 
rejection of the AM developed two weeks after surgery. This patient was 
leukopenic and the histopathologic examination of the sequestrum of this eye 
revealed large aggregates of bacterial cocci and intense neutrophilic infiltration 
(Fig 4b). This was in contrast to the more typical corneal sequestra composed of 
large areas of acellular, tan collagen fibers only occasionally demarcated 
peripherally by leukocytes (Fig 4a). The cornea was epithelialized after rejection 
of the AM and the patient was lost to follow up for 3 months. After this period 
the cat was re-presented with a descemetocele in the same area of the previous 
AM necrosis; a conjunctival pedicle graft was performed at this time.  
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In a second eye (case 5, table 1) a corneal perforation occurred under the AM 
two weeks after surgery. The sequestrum of this cornea was deep and without 
vascularization. A conjunctival pedicle graft was performed to repair the lesion. 
 
 Table 1.  Signalment, clinical parameters and surgical outcomes in 6 cats (7 eyes) treated with lamellar 
keratectomy and amniotic membrane transplantation 
 
 
Depth: s: < 1/3 corneal stroma; m: >1/3, < 2/3; p> 2/3 
fs =female spayed 
m= intact male 
mc= male castrated 
os= left eye 
od=right eye 
++ =  severe 
+ = moderate 
- =  absent 
 
 
 
 
 
N° breed Age 
(yrs) 
gender eye depth vascularization Eye 
disease 
histopath Clinical 
outcome 
1 Persian 2 fs os p ++ entropion typical good 
2 Domestic 
shorthair 
12 fs od p ++  Bacteria 
++ 
necrosis 
and 
rejection 
3 Persian 6.5 m os m + entropion typical good 
4 Domestic 
shorthair 
2 fs os m + ree typical good 
5 Persian 6.5 fs od p - entropion typical corneal 
perforation  
     os s - entropion typical good 
6 Persian 3 mc os m ++  typical good 
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Figure 2. (a) Preoperative appearance of the corneal sequestrum in case 1. (b) Immediate 
postoperative appearance of amniotic membrane transplant. A peripheral corneal vascular response 
and vascularization of the deep stroma in keratectomy site may be seen. (c) Appearance of the eye 3 
weeks postoperatively. A central corneal granulation tissue developed on the AM. (d) Appearance of 
the eye 12 weeks postoperatively. Substantial clearing of the graft and resolution of the pre-existing 
corneal vascularization is noted. 
a 
a 
a b 
c d 
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Figure 3. (a) Preoperative appearance of the corneal sequestrum in case 3. (b) Immediate 
postoperative appearance of the amniotic membrane transplant. (c) Appearance of the eye 5 weeks 
postoperatively. A granulation tissue developed on the AM with a peculiar brown area in the center; 
this area could be a partial necrosis  in the last point that was vascularized.  (d) Appearance of the eye 
20 weeks postoperatively. Progressive regression of the granulation tissue and the necrotic portion of 
the AM. 
 
Figure 4. Histological sections (6 mm) (a) typical corneal sequestrum: degenerated corneal fibrils with 
a characteristic brown pigmentation and sparse spindle cells; (b) corneal sequestrum of case 3: large 
aggregates of coccoid bacteria are present among fibrils. H&E, original magnification 400x. (Courtesy 
Dr. Chiara Giudice) 
a b 
c d 
a b 
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4.3 Dogs 
One dog was a 5 year old, female Shitzu, affected by stromal corneal ulcer in the 
right cornea. The ulcer was infected, with moderate vascularization and of more 
than 2/3 of corneal thickness deep.  
The other two dogs were affected by lateral corneo-conjunctival dermoid in the 
right eye. They were two German shepherds, one male and one female of 6 and 
10 months of age respectively. In both dogs the dermoids extended to the lateral 
cantus.  
Immediately after surgery no discomfort was noted. In all the eyes there was an 
epithelial proliferation over the amnion within the first 2-4 days after surgery, 
followed by a second phase of corneal granulation tissue proliferation in the next 
2-5 weeks and a third phase of corneal clearing in the following weeks. The 
granulation tissue was particularly evident on the conjunctival area of the excised  
dermoid (Fig 5).  During the last phase an almost complete regression of the 
preexisting vascularization and granulation tissue was noted, with a good corneal 
transparency in all the patients. 
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Figure 5. (a) Preoperative appearance of the corneo-conjunctival dermoid in a dog. (b) Immediate 
postoperative appearance of amniotic membrane transplant and lateral cantoplasty after excision of the 
dermoid. (c) Appearance of the eye 1 week postoperatively. A lateral corneo-conjunctival granulation 
tissue developed on the AM. (d) Appearance of the eye 3 weeks postoperatively. A clearing of the graft 
and no recurrence of dermoid are noted. 
a b 
c d 
37 
 
4.4 Horses 
Five of the eleven horses were castrated male, four female and two foals, one 
male and one female. Breeds affected included: 1 paint, 1 appaloosa, 1 IRL, 1 
KWPN, 1 French trotters, 2 Dutch, 2 Italian trotters and 2 thoroughbreds. Age 
ranged from 4 months to 19 years (median  7.5 years). Three patients were 
treated for melting ulcer (Fig 6), four for fungal ulcer (Fig 7), two for corneo-
conjunctival squamous cell carcinoma (SCC) (Fig 8), one for immune-mediated 
keratitis (IMMK) and one for chronic corneal edema. In the eyes with fungal 
ulcer amniotic membrane was rejected after  a median of 9 days (range 7 to 15 
days), leaving a stromal corneal defect, not infected and partially epithelized in 
three patients. In the two foals, treated for melting ulcer, the amnion was 
rejected rispectively  at 2 and 3 weeks from surgery, leaving an epithelized 
corneal scar. In the others patients the AM was epithelized in the first week after 
surgery and progressively vascularized  and integrated in the cornea. Corneal scar 
was mild in seven eyes, moderate in two and severe in two. In these last two 
subjects we had some complications: one eye, seriously  affected by deep fungal 
ulcer, had an endothelitis  with consequent secondary uveitis and phthisis bulbi; 
in the seconde eye a corneal perforation developed under the amnion. In this 
case we performed a conjunctival pedicle graft. Visual function was good in 
seven eyes, subtle in two, bare in the eye with corneal edema, for partial 
persistence of the edema, and absent in the phthisic eye.   
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Table 2.  Signalment, clinical parameters and surgical outcomes in 11 horses treated with lamellar 
keratectomy and amniotic membrane transplantation 
 
m= intact male 
mc= male castrated 
os= left eye 
od=right eye 
mi= mild 
mo = moderate 
s =  severe 
+++= good 
++= subtle 
+= bare 
-= absent 
 
N° breed Age 
(yrs) 
gender eye diagnosis Corneal  
scar 
complication vision FU 
(months) 
1 paint 8 mc os SCC mi  +++ 10 
2 IRL 9 mc od edema mi  + 5 
3 Italian trotter 
13 mc os 
Fungal ul. 
s 
Endothelitis 
Phthisis b. - 3 
4 Italian trotter 3 f os melting mi  +++ 12 
5 Frech trotter 10 f od Fungal ul. mi  +++ 4 
6 Dutch 10 mc os Fungal ul. s perforation ++ 5 
7 Dutch 8 f os Fungal ul mi  +++ 10 
8 appaloosa 19 f os SCC mo  ++ 8 
9 KWPN 9 mc os IMMK mi  ++ 3 
10 thoroughbreds 0,33 m od melting mo  +++ 1 
11 thoroughbreds 0,33 f od melting mo  +++ 1 
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Figure 6. (a) Preoperative appearance of the corneal meltimng ulcer in case 4. (b) Appearance of the 
amniotic membrane transplant 2 days after surgery. (c) Appearance of the eye 1 month postoperatively. 
A central corneal granulation tissue and neovascularization developed on the AM. (d) Appearance of 
the eye 12 months postoperatively. Substantial clearing of the graft and resolution of the pre-existing 
corneal vascularization is noted. (Courtesy Dr. Riccardo Stoppini) 
 
 
 
 
 
 
 
 
 
 
a b 
c d 
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Figure 7. (a) Preoperative appearance of the fungal ulcer in case 7. (b) Appearance of amniotic 
membrane transplant rejection 10 days after surgery. A peripheral corneal vascular response may be 
seen. (c) Appearance of the eye 1 month postoperatively. A central corneal granulation tissue 
developed. (d) Appearance of the eye 10 months postoperatively. Substantial clearing of the cornea 
and resolution of the pre-existing corneal vascularization is noted. (Courtesy Dr. Riccardo Stoppini) 
 
 
 
 
 
 
 
 
 
a b 
c d 
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Figure 8. (a) Preoperative appearance of the corneo-conjunctival squamous cell carcinoma in case 1. 
(b) Appearance of amniotic membrane transplant 4 days after surgery (c) Appearance of the eye 3 
weeks postoperatively. Granulation tissue developed on the AM, particularly on the conjunctival area. 
(d) Appearance of the eye 10 months postoperatively. Substantial clearing of the graft is noted, there is 
no sign of recurrence. (Courtesy Dr. Riccardo Stoppini) 
 
 
 
 
 
 
 
 
 
a b 
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5. Discussion and conclusion 
AM transplantation (AMT) has been widely described in human ophthalmology 
for the reconstruction of corneal and/or conjunctival surface in different 
diseases, such as: ocular surface neoplasia,11 pterygium,11,17,18 chemical and 
thermal burns,11,19,20 cicatrizing conjunctivitis,11 symblepharon release,11,17 bleb 
leakage,11 filtering surgery,11,21 persistent epithelial defects,11,22 non healing 
stromal ulcers,11 deep stromal ulcers and descemetoceles,23 neurotrophic 
keratopathy,24 limbal stem cells deficiency,25 bullous keratopathy,11,26 infectious 
keratitis,27 Stevens Johnson syndrome,28,29 melting ulcers,11 scleral melt11 and 
band keratopathy.11 In veterinary ophthalmology AMT has been described for 
the treatment of ocular surface neoplasia,7,8,30 bullous keratopaty,8 melting 
ulcers,7,8,31 symblepharon,7 immun-mediated keratitis8 and in conjunction with 
penetrating keratoplasty.8   
To the authors knowledge there is no report in the literature about the use of 
AMT as a treatment for feline corneal sequestrum. When compared with other 
surgical techniques proposed in the literature for corneal sequestrum, AMT can 
be considered among those with optimal results. Specifically, lamellar 
keratectomy with secondary placement of a pedicle conjunctival graft has been 
used by some authors1 and seems to facilitates healing by providing a direct 
blood supply to the lesion and by providing tectonic support. It also seems to 
reduce the recurrence rate of the sequestrum after keratectomy, however it has 
been associated with secondary corneal scarring of varying density.1 Lamellar 
keratoplasty has been described by Pena et al. in 6 eyes that had an optimal 
cosmetic outcome and no evidence of recurrence of the sequestra for a 4-30 
months follow-up periods.4 Corneoconjunctival transposition has been reported 
in17 cases by Andrew et al. with minimal scarring from the transposed limbus 
and no recurrence for a 30 days – 7 years follow-up time. 2 Heterologous 
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penetrating keratoplasty has also been described in one case for a dense, full-
thickness corneal sequestrum.3 However, in the case reported this technique had 
a poor outcome. At 9 days postoperatively, the cornea had severe edema, most 
likely due to diffuse endothelial graft rejection, although at 16 months 
postoperatively, the cornea had a faint central nebula at the site of surgery. 3 In 
our case series  a successful outcome was obtained with AMT in five out of 
seven eyes: the AM epithelialized quickly and, after the fibrovascular invasion of 
the AM, all the corneas had good transparency, with no sequestrum recurrence 
detected in our follow-up periods.  
In two cases we had complications. In one eye there was a partial necrosis of the 
amnion. This patient was leucopenic and the sequestrum showed a very high 
bacterial invasion and neutrophilic infiltration. This could justify a higher 
proteinase activity that couldn’t be controlled by the AM. The same bacterial 
contamination could have caused a melting process in the cornea and the 
formation of the descemetocele after three months from the AM necrosis. 
Another case showed a perforation under the AM. In 2008 M. Kaup et al. 
described a case series of AMT where descemetocele and spontaneous corneal 
perforation occurred in 25% of the patients. To the authors these complications 
could be explained by the inhibiting influence of AM on corneal fibroblasts. The 
suppression of the myofibroblast differentiation by AM might explain the risk of 
corneal thinning and perforation after AMT in patients with corneal surface 
disorders. Furthermore an increased levels of matrix metalloproteinase-9 after 
this corneal surgery may be a second reason for corneal perforation after AMT.32 
Our patient had a deep sequestrum without any vascularization and this could 
explain the risk of corneal thinning and of increased level of metalloproteinases. 
In conclusion, lamellar keratectomy and AMT could be an effective treatment 
for feline corneal sequestrum, with increased animal comfort and good corneal 
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transparency. A selection of the patients should be done, particularly for the very 
deep and not vascularized sequestra.   
We also had really good results in the canine patients, without complications. 
There is no report in literature about the use of AMT after dermoid removal. In 
our two cases we had good cosmetic and functional results. More dermoid cases 
are needed to compare this technique to the traditional simple excision or the 
use of conjunctival graft.    
Our results of the AMT in horses are similar to the data in the international 
literature. In our cases we used the inlay technique, and the amnion was placed 
with the basal membrane side up in those lesions where the integration of the 
AM is needed (melting ulcers, keratectomy bed after SCC excision or edema). In 
the fungal ulcers the amniotic basal membrane was placed side down. In these 
lesions the objective was, not only to have benefit from AM properties, but also 
to induce the migration of the residual fungi on the amnion. Even if it is not 
published yet, this technique is used by several colleagues. The fungi, indeed, are 
attracted by the glycoproteins  of the amnion basal membrane.36,37 The 
subsequent rejection of the amnion in these cases would  consent the removal of 
the fungi.  
We had complications in two patients. Both cases were affected by  severe, deep 
fungal ulcer. The first horse developed an endothelitis one month after surgery; 
the second one had a corneal perforation under the amnion. These 
complications could be caused by the severe fungal infection and the 
impossibility to completely remove the fungi, with consequent progression of 
the lesion and collagenolisis.   
In the other equine patients we had good cosmetic and functional results. We 
can conclude that AMT is an excellent alternative to the use of conjunctival graft 
or other surgical techniques that usually induce the formation of severe corneal 
scars, with visual deficits.  
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